UNION therapeutics A/S: Financial statements 2014
CVR: 33963750
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
UNION therapeutics A/S (CVR 33963750) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 3,055,657 and a net result of DKK 578,227 compared with DKK 359,099 the year before. That is an increase of 154.1% compared with the year before. Equity in the 2014 report amounted to DKK 988,379. The solvency ratio was 31.9%.
- Gross Profit
- DKK 3,055,657
- Profit/Loss
- DKK 578,227
- Equity
- DKK 988,379
- Total Assets
- DKK 3,094,069
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
UNION therapeutics A/S has published its annual report for 2013. Gross profit came to DKK 1,202,613, and the net result was DKK 359,099.
About UNION therapeutics A/S
UNION therapeutics A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AntibioTx A/S and ANTIBIOTX ApS. The management consists of Kim Domela Kjøller, Morten Otto Alexander Sommer and Rasmus Vendler Toft-Kehler. The board consists of Stig Løkke Pedersen (chair), Andrew John Oakley, Morten Otto Alexander Sommer and Peter Kristensen. The company's owners include MANJIN ApS, VENDLER ApS and T&W HOLDING A/S. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -11,802,644 and a net result of DKK -32,142,051 compared with DKK -98,922,000 the year before. Equity in the 2025 report amounted to DKK -147,650,138.